FFA
AXSM icon

Farther Finance Advisors’s Axsome Therapeutics AXSM Stock Holding History

Farther Finance Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50.2K Buy
292
+18
+7% +$3.11K ﹤0.01% 2995
2025
Q4 		$50K Buy
274
+235
+603% +$32.8K ﹤0.01% 2816
2025
Q3 		$4.74K Buy
39
+10
+34% +$1.13K ﹤0.01% 3789
2025
Q2 		$3.03K Sell
29
-10
-26% -$1.06K ﹤0.01% 3552
2025
Q1 		$4.36K Sell
39
-3
-7% -$342 ﹤0.01% 3118
2024
Q4 		$3.55K Hold
42
– – ﹤0.01% 2803
2024
Q3 		$3.77K Hold
42
– – ﹤0.01% 2764
2024
Q2 		$3.4K Buy
42
+32
+320% +$2.37K ﹤0.01% 2566
2024
Q1 		$770 Sell
10
-1
-9% -$84 ﹤0.01% 2872
2023
Q4 		$875 Buy
+11
New +$735 ﹤0.01% 2787

Other funds holding AXSM

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return